Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) Gross Margin (2022 - 2025)

TriSalus Life Sciences (TLSI) has 3 years of Gross Margin data on record, last reported at 86.66% in Q4 2025.

  • For Q4 2025, Gross Margin rose 138.0% year-over-year to 86.66%; the TTM value through Dec 2025 reached 84.57%, down 148.0%, while the annual FY2025 figure was 84.57%, 148.0% down from the prior year.
  • Gross Margin reached 86.66% in Q4 2025 per TLSI's latest filing, up from 83.52% in the prior quarter.
  • Across five years, Gross Margin topped out at 89.84% in Q4 2023 and bottomed at 77.82% in Q1 2023.
  • Average Gross Margin over 3 years is 85.13%, with a median of 85.12% recorded in 2024.
  • The widest YoY moves for Gross Margin: up 715bps in 2024, down -456bps in 2024.
  • A 3-year view of Gross Margin shows it stood at 89.84% in 2023, then dropped by -5bps to 85.28% in 2024, then increased by 2bps to 86.66% in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Margin were 86.66% in Q4 2025, 83.52% in Q3 2025, and 83.93% in Q2 2025.